Human binding molecules having killing activity against enterococci and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 14, 2011
Grant Date -
Jul 2, 2009
app pub date -
Jun 5, 2007
filing date -
Jun 6, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides human binding molecules specifically binding to enterococci and having killing activity against enterococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from Enterococcus.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully